Series A · BiotechBrenus Pharma: Series ADevelops an off-the-shelf in vivo immunotherapy platform for solid tumorsPublished Oct 4, 2026By RoundOS Funding deskFunding historyJul 20, 2026Series A · This round€11MSourcesbusinesswire.com↗
AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120MSeries C · Aug 27, 2026
ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35MStrategic · Aug 27, 2026
TransfyrPhysical AI platform capturing real-world lab science into machine-readable data$25MSeed · Aug 26, 2026
Airway TherapeuticsDevelops biologic therapies for respiratory and infectious diseases$50MSeries E2 · Aug 25, 2026